 European experience itraconazole systemic mycoses January patients deep fungal infections itraconazole mg/day Northern Italy Evaluation drug efficacy tolerance possible patient sporotrichosis aspergillosis cryptococcosis mainly patients positive human immunodeficiency virus Response case sporotrichosis patients different forms aspergillosis patients invasive pulmonary aspergillosis Patients cryptococcosis itraconazole active infection and/or prevention relapse Active infection itraconazole patients itraconazole flucytosine patients patients itraconazole maintenance therapy months relapses relapses decline serum antigen serum antigen titer exception hypokalemia patient itraconazole patients drug several months years